Metraipolis › archive › dc_afa7420cd8d1

High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome Inhibitor — Europe PMC PMID:42039709

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42039709
DOI
10.1002/mco2.70695
License (as archived)
solo-consultazione
Archived
2026-11-03T07:39:33.074Z
SHA-256 of the archived text
cfd325ea9033962e92a2c9df7eaa8d7518f68bfbaa8da07f5cdb0f6009ec1e5e
Stable URL of this page
https://metraipolis.com/documento/dc_afa7420cd8d1

How to cite

High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome Inhibitor — Europe PMC PMID:42039709 — Europe PMC (en), https://europepmc.org/article/MED/42039709 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afa7420cd8d1 (Metraipolis archive dc_afa7420cd8d1, sha256 cfd325ea9033962e92a2c9df7eaa8d7518f68bfbaa8da07f5cdb0f6009ec1e5e)
BibTeX
@misc{dcafa7420cd8d1,
  title = {High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome Inhibitor — Europe PMC PMID:42039709},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42039709},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afa7420cd8d1; sha256 cfd325ea9033962e92a2c9df7eaa8d7518f68bfbaa8da07f5cdb0f6009ec1e5e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42039709. Agents can read the archived copy with the MCP tool read_document.